tirzepatide category Dosing Chart 2026: 2.5-15 mg Titration & Units Tirzepatide | C225H348N48O68 | CID

Studies report that third-generation oral contraceptives improve overall treatment outcomes by 33% (132)

Weight management (and the treatment of weight-related comorbidities) is not one-size-fits-all

Depending on your prior Mounjaro dosage, your clinician may start Wegovy at a moderate dose and then titrate up gradually, based on tolerance and response

External resources SURMOUNT-1 Trial Publication, New England Journal of Medicine - The landmark clinical trial data for tirzepatide in obesity treatment FDA Prescribing Information for Mounjaro (tirzepatide) - Official FDA label with complete dosing, safety, and pharmacological information Mayo Clinic: Tirzepatide Side Effects and Dosage - Patient-focused overview of side effects, precautions, and proper use Eli Lilly Medical: How Should Tirzepatide Doses Be Increased - Manufacturer guidance on dose escalation from the company behind Mounjaro PubMed Central: SURMOUNT-MAINTAIN Trial Design - Research on maintaining weight loss after initial tirzepatide treatment Understanding tirzepatide dosing in units is not complicated once you know the formula and have the right charts